RBC, heal thyself: PK activators in SCD
- PMID: 36355466
- DOI: 10.1182/blood.2022016930
RBC, heal thyself: PK activators in SCD
Comment on
-
A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease.Blood. 2022 Nov 10;140(19):2053-2062. doi: 10.1182/blood.2022015403. Blood. 2022. PMID: 35576529 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical